OH Pharma
Products › Metabolism › Semaglutide 10 mg
Semaglutide 10 mg OH PharmaSemaglutide 10 mg OH Pharma – back of vial

Metabolism · File 19

Semaglutide 10 mg

Analysis in progress

✓Sterility and endotoxins tested by Nelson Labs (Salt Lake City)

Incretin receptor agonists (GLP-1, GIP, glucagon).

Calculate a dose →

Description

GLP-1 receptor agonist, a gut hormone involved in regulating appetite and blood sugar.

Studied benefits

  • Reduced appetite and increased satiety.
  • Weight loss and improved blood-sugar control in type 2 diabetes.
  • Reduced risk of heart attack, stroke and cardiovascular death in some people with cardiovascular disease and excess weight.
  • Reduced risk of worsening kidney disease in people with type 2 diabetes and chronic kidney disease.
  • Treatment of some forms of MASH, an inflammatory liver disease linked to fat build-up, with moderate to advanced fibrosis.

Results reported in published research; they guarantee no effect and are not an indication for use.

🔬 What the research says
  • STEP 1 trial (NEJM, 2021; 1,961 adults, 68 weeks): mean weight loss of 14.9% with semaglutide 2.4 mg weekly, versus 2.4% on placebo.
  • Used by prescription for type 2 diabetes and weight management.
⚠️ Warnings and reported side effects
  • Common digestive effects: nausea, diarrhea, vomiting, constipation.
  • GLP‑1 class warnings: pancreatitis, gallbladder disorders, thyroid tumours seen in rodents; contraindicated with a history of medullary thyroid cancer.
  • Risk of hypoglycemia if combined with insulin or certain diabetes medications. Not recommended during pregnancy.

Consult a healthcare professional before any use. If an adverse effect occurs, stop use and see a doctor.

Certificate of analysis coming soon

This product's lot is awaiting its laboratory results. The certificate will be published on this page as soon as it is received. Every new lot is sent for analysis before being published here.

Sources

  1. Wilding et al., NEJM 2021 — STEP 1 trial

For educational purposes only. This information summarizes published studies and is neither a recommendation for use nor medical advice.

← Back to products